ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target.

Alfredo Perales-Puchalt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.